Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$26.87 0.34 (1.28%) as of 4:30 Tue 4/16


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.33(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.32 - $47.5
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 201,796 329,048
Total Sell Value $3,656,226 $3,656,226 $6,836,738 $14,896,079
Total People Sold 1 1 15 17
Total Sell Transactions 3 3 36 63
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 264
  Page 3 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brege Laura Director   –       •      –    2014-05-09 4 AS $73.57 $738,450 D/D (10,000) 0     -
   Brege Laura Director   –       •      –    2014-05-09 4 OE $10.81 $117,610 D/D 10,000 10,000     -
   Wicki Andreas Director   –       •      –    2014-05-08 4 AS $75.76 $1,759,215 I/I (23,220) 1,599,307     -
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-05-08 4 AS $74.27 $1,125,681 D/D (15,000) 5,000     -
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-05-08 4 OE $1.61 $24,150 D/D 15,000 20,000     -
   Wicki Andreas Director   –       •      –    2014-05-07 4 AS $75.64 $45,386 I/I (600) 1,622,527     -
   Wicki Andreas Director   –       •      –    2014-05-06 4 AS $75.78 $3,348,062 I/I (44,180) 1,623,127     -
   Longenecker John P Phd Director   –       •      –    2014-03-28 4 AS $64.63 $64,630 D/D (1,000) 0     -
   Longenecker John P Phd Director   –       •      –    2014-03-28 4 OE $29.90 $29,900 D/D 1,000 1,000     -
   Stack David M President, CEO and Chairman   •       •      –    2014-03-11 4 A $0.00 $0 D/D 221 1,208     -
   Patou Gary Chief Medical Officer   •       –      –    2014-03-11 4 A $0.00 $0 I/I 504 702     -
   Wicki Andreas Director   –       •      –    2014-03-06 4 S $80.11 $176,244 I/I (2,200) 1,667,307     -
   Wicki Andreas Director   –       •      –    2014-03-05 4 S $80.16 $1,818,651 I/I (22,687) 1,669,507     -
   Stack David M President and CEO   •       •      –    2013-12-30 4 AS $55.84 $837,560 D/D (15,000) 2,987     -
   Stack David M President and CEO   •       •      –    2013-12-30 4 OE $1.61 $24,150 D/D 15,000 17,987     -
   Longenecker John P Phd Director   –       •      –    2013-12-30 4 AS $55.55 $138,875 D/D (2,500) 0     -
   Longenecker John P Phd Director   –       •      –    2013-12-30 4 OE $1.61 $4,025 D/D 2,500 2,500     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-12-30 4 AS $55.55 $555,500 D/D (10,000) 5,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-12-30 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Stack David M President and CEO   •       •      –    2013-11-18 4 A $0.00 $0 D/D 414 2,987     -
   Patou Gary Chief Medical Officer   •       –      –    2013-11-18 4 A $0.00 $0 I/I 83 198     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-11-06 4 AS $50.60 $2,556,980 D/D (50,000) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-11-06 4 OE $10.81 $540,500 D/D 50,000 50,000     -
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 AS $48.92 $978,400 D/D (20,000) 0     -
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 OE $1.61 $32,200 D/D 20,000 20,000     -
  264 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us